Jihyung Hong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jihyung Hong has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Diego Novick
Eli Lilly and Company, Windlesham, Surrey, United Kingdom
6 shared publicationsHéctor Dueñas
Eli Lilly de Mexico, Mexico City
4 shared publications- Josep Maria Haro
Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu (IRSJD), Sant Boi de Llobregat, Spain
4 shared publications William Montgomery
Eli Lilly Australia Pty Ltd, Sydney, NSW, Australia
4 shared publicationsEun-Young Bae
College of Pharmacy, Gyeongsang National University, Jinju, Republic of Korea
3 shared publicationsJosep Maria Haro
Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain
3 shared publications
Latest Publications
- 8 May 2025
- Published by Elsevier in Value in Health
- Vol. 28 (8) , 1259-1267
The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public
- 8 May 2025
- Published by Elsevier in Value in Health
- Vol. 28 (8) , 1259-1267
The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public
- Open Access
- 1 August 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1215914
The impact of the COVID-19 pandemic on life expectancy by the level of area deprivation in South Korea
Objective: Comparative evidence suggests that the impact of COVID-19 on life expectancy has been relatively milder in South Korea. This study aims to examine whether the pandemic has universal or unequal impacts on life expectancy across 250 districts with varying levels of deprivation.Methods: Using mortality data from 2012 to 2021 obtained from the Microdata Integrated Service of Statistics Korea, we calculated life expectancy at birth and age 65 for both sexes, by deprivation quintiles, before and during the pandemic. We summarized life expectancy gaps using the slope of the inequality index (SII) and further decomposed the gaps by the contribution of age and cause of death using Arriaga’s method.Results: Both men and women experienced consistent improvements in life expectancy from 2012 to 2019, but the trend was disrupted during 2020 and 2021, primarily driven by older people. While men in more deprived areas were initially hit harder by the pandemic, the life expectancy gap across deprivation quintiles remained relatively constant and persistent across the study period [SII: -2.48 (CI: −2.70 from −2.27) for 2019 and − 2.84 (CI: −3.06 from −2.63) for 2020]. Middle-aged men from the most deprived areas were the most significant contributors to the life expectancy gap, with liver disease, liver cancer, transport accidents, and intentional injuries being the leading causes, both in the pre and during the pandemic. While these contributors remained largely similar before and during the pandemic, the contribution of transport accidents and liver cancer to the male life expectancy gap slightly decreased during the pandemic, while that of ischemic heart disease and pneumonia slightly increased. A similar increase was also observed for the female life expectancy gap.Conclusion: This study found no clear evidence of an increased life expectancy gap during the pandemic in South Korea, unlike in other countries, although access to emergency healthcare services may have been slightly more disturbed in deprived areas. This achievement can provide lessons for other countries. However, the persistent regional gaps in life expectancy observed over the past decade indicate the need for more targeted public health policies to address this issue.
- 1 August 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1215914
Open AccessThe impact of the COVID-19 pandemic on life expectancy by the level of area deprivation in South Korea
Objective: Comparative evidence suggests that the impact of COVID-19 on life expectancy has been relatively milder in South Korea. This study aims to examine whether the pandemic has universal or unequal impacts on life expectancy across 250 districts with varying levels of deprivation.Methods: Using mortality data from 2012 to 2021 obtained from the Microdata Integrated Service of Statistics Korea, we calculated life expectancy at birth and age 65 for both sexes, by deprivation quintiles, before and during the pandemic. We summarized life expectancy gaps using the slope of the inequality index (SII) and further decomposed the gaps by the contribution of age and cause of death using Arriaga’s method.Results: Both men and women experienced consistent improvements in life expectancy from 2012 to 2019, but the trend was disrupted during 2020 and 2021, primarily driven by older people. While men in more deprived areas were initially hit harder by the pandemic, the life expectancy gap across deprivation quintiles remained relatively constant and persistent across the study period [SII: -2.48 (CI: −2.70 from −2.27) for 2019 and − 2.84 (CI: −3.06 from −2.63) for 2020]. Middle-aged men from the most deprived areas were the most significant contributors to the life expectancy gap, with liver disease, liver cancer, transport accidents, and intentional injuries being the leading causes, both in the pre and during the pandemic. While these contributors remained largely similar before and during the pandemic, the contribution of transport accidents and liver cancer to the male life expectancy gap slightly decreased during the pandemic, while that of ischemic heart disease and pneumonia slightly increased. A similar increase was also observed for the female life expectancy gap.Conclusion: This study found no clear evidence of an increased life expectancy gap during the pandemic in South Korea, unlike in other countries, although access to emergency healthcare services may have been slightly more disturbed in deprived areas. This achievement can provide lessons for other countries. However, the persistent regional gaps in life expectancy observed over the past decade indicate the need for more targeted public health policies to address this issue.
- 22 July 2022
- Published by Springer Nature in Applied Health Economics and Health Policy
- Vol. 20 (6) , 819-834
Systematic Review and Quality Assessment of Health Economic Evaluation Studies (2007–2019) Conducted in South Korea
Background South Korea formally adopted economic evaluation in December 2006 to aid drug reimbursement decision-making. While this policy change is applied only to pharmaceuticals, it has also sparked interest in economic evaluations for non-pharmaceutical interventions and programmes. Objective This study aimed to provide a snapshot of the current practice for published health economic evaluation studies and critically assess the quality of these studies. Methods An electronic search was performed on multiple databases (EMBASE, PubMed, NHS Economic Evaluation Database, Scopus, Korean Medical database, Korean studies Information Service System, and Research Information Sharing Service) to identify health economic evaluation studies published between January 2007 and December 2019. The inclusion criteria were peer-reviewed, original health economic evaluations (cost-utility, cost-effectiveness, cost-minimisation, and cost–benefit analyses) published in English or Korean. Two reviewers selected studies for inclusion and extracted data from the included studies. Key characteristics of these studies were descriptively summarised, and study quality was assessed using the Quality of Health Economic Studies (QHES) instrument on a 100-point scale. Results A total of 162 studies were included in this review (63 for drugs, 51 for non-pharmaceutical treatments/health technologies, and 48 for health programmes). These numbers confirm a significant increase in the number of publications since the policy introduction. However, the quality of these studies remained relatively low, with a mean QHES score of 57.9 (± 16.0). Study quality also varied substantially, with the QHES scores ranging from 15 to 87. The scores were notably lower in studies with non-pharmaceutical interventions and programmes, cost-effectiveness analyses or cost–benefit analyses, retrospective study-based or simple modelling-based analyses, and those locally published. In addition, a considerable proportion of these studies did not state or specify essential components of economic evaluation, such as perspectives (30.2%), time horizons (29.6%), discount rates (34.6%), and sensitivity analyses (24.7%). While the use of local data either fully or partially was relatively higher for unit costs (94.4%) and resource utilisation (90.1%), it was lower for utility weights (47.1%), treatment effects (63.0%), and baseline risks (70.4%). Transferability or generalisability issues were infrequently discussed when relying on foreign sources. In addition, the included studies were often not well structured, making it difficult to assess their quality. Conclusion These findings suggest that there is still much room for improving the quality of health economic evaluation studies conducted in South Korea. Policymakers should critically evaluate available cost-effectiveness evidence, especially for non-pharmaceutical interventions and programmes, when using it for decision-making in South Korea.
- 22 July 2022
- Published by Springer Nature in Applied Health Economics and Health Policy
- Vol. 20 (6) , 819-834
Systematic Review and Quality Assessment of Health Economic Evaluation Studies (2007–2019) Conducted in South Korea
Background South Korea formally adopted economic evaluation in December 2006 to aid drug reimbursement decision-making. While this policy change is applied only to pharmaceuticals, it has also sparked interest in economic evaluations for non-pharmaceutical interventions and programmes. Objective This study aimed to provide a snapshot of the current practice for published health economic evaluation studies and critically assess the quality of these studies. Methods An electronic search was performed on multiple databases (EMBASE, PubMed, NHS Economic Evaluation Database, Scopus, Korean Medical database, Korean studies Information Service System, and Research Information Sharing Service) to identify health economic evaluation studies published between January 2007 and December 2019. The inclusion criteria were peer-reviewed, original health economic evaluations (cost-utility, cost-effectiveness, cost-minimisation, and cost–benefit analyses) published in English or Korean. Two reviewers selected studies for inclusion and extracted data from the included studies. Key characteristics of these studies were descriptively summarised, and study quality was assessed using the Quality of Health Economic Studies (QHES) instrument on a 100-point scale. Results A total of 162 studies were included in this review (63 for drugs, 51 for non-pharmaceutical treatments/health technologies, and 48 for health programmes). These numbers confirm a significant increase in the number of publications since the policy introduction. However, the quality of these studies remained relatively low, with a mean QHES score of 57.9 (± 16.0). Study quality also varied substantially, with the QHES scores ranging from 15 to 87. The scores were notably lower in studies with non-pharmaceutical interventions and programmes, cost-effectiveness analyses or cost–benefit analyses, retrospective study-based or simple modelling-based analyses, and those locally published. In addition, a considerable proportion of these studies did not state or specify essential components of economic evaluation, such as perspectives (30.2%), time horizons (29.6%), discount rates (34.6%), and sensitivity analyses (24.7%). While the use of local data either fully or partially was relatively higher for unit costs (94.4%) and resource utilisation (90.1%), it was lower for utility weights (47.1%), treatment effects (63.0%), and baseline risks (70.4%). Transferability or generalisability issues were infrequently discussed when relying on foreign sources. In addition, the included studies were often not well structured, making it difficult to assess their quality. Conclusion These findings suggest that there is still much room for improving the quality of health economic evaluation studies conducted in South Korea. Policymakers should critically evaluate available cost-effectiveness evidence, especially for non-pharmaceutical interventions and programmes, when using it for decision-making in South Korea.
- 28 July 2021
- Published by Springer Nature in PharmacoEconomics
- Vol. 39 (10) , 1109-1121
A Review of Utility Measurement Methods Used in Pharmacoeconomic Submissions to HIRA in South Korea: Methodological Consistency and Areas for Improvement
Pharmacoeconomic (PE) guidelines, first published in 2006 and later updated in 2011, were developed to guide the preparation and submission of PE data to the Health Insurance Review and Assessment Service (HIRA) for drug reimbursement decision making in South Korea. This study, which was conducted as part of a project for revision of the PE guideline, reviewed utility values used in the PE submissions processed at HIRA during 2014–2018 to identify aspects of the current guidelines that may need to be revisited. A total of 50 PE submissions were processed at HIRA over the 5 years. Of these, 47 submissions that used quality-adjusted life-years as an outcome measure were included in this review. Data were extracted from full copies of the manufacturer’s initial submissions and committee documents provided by HIRA. Of the 47 submissions, nearly half (n = 23, 48.9%) used published sources to obtain health state utility values, followed by direct methods using time trade-off (n = 7) or standard gamble (n = 2) and indirect methods with patient-level data using the EQ-5D-3L (n = 4) or the EQ-5D-5L (n = 2). Mapping, using the EQ-5D-3L as a target measure, was also adopted in six submissions, although it was somewhat unfavourably described in the guideline. Notably, 52.2% of the submissions with published sources took utility values from different sources for different health states defined in a single model. In addition, details of utility measurement methods or mapping functions taken from published sources were relatively poorly reported. Moreover, the preferences of the Korean general public, preferred by the guideline, were rarely reflected in the utility values used in submissions relying on published sources (95.7% for foreign values only/mixed) and mapping (66.7%). While most submissions with direct and indirect methods used domestic preference values, the former was occasionally criticised by assessment committees because of health state descriptions. This review highlights a considerable amount of inconsistency in the measurement of utility values used in the PE submissions during 2014–2018, indicating a strong need for methodological standardisation.
- 28 July 2021
- Published by Springer Nature in PharmacoEconomics
- Vol. 39 (10) , 1109-1121
A Review of Utility Measurement Methods Used in Pharmacoeconomic Submissions to HIRA in South Korea: Methodological Consistency and Areas for Improvement
Pharmacoeconomic (PE) guidelines, first published in 2006 and later updated in 2011, were developed to guide the preparation and submission of PE data to the Health Insurance Review and Assessment Service (HIRA) for drug reimbursement decision making in South Korea. This study, which was conducted as part of a project for revision of the PE guideline, reviewed utility values used in the PE submissions processed at HIRA during 2014–2018 to identify aspects of the current guidelines that may need to be revisited. A total of 50 PE submissions were processed at HIRA over the 5 years. Of these, 47 submissions that used quality-adjusted life-years as an outcome measure were included in this review. Data were extracted from full copies of the manufacturer’s initial submissions and committee documents provided by HIRA. Of the 47 submissions, nearly half (n = 23, 48.9%) used published sources to obtain health state utility values, followed by direct methods using time trade-off (n = 7) or standard gamble (n = 2) and indirect methods with patient-level data using the EQ-5D-3L (n = 4) or the EQ-5D-5L (n = 2). Mapping, using the EQ-5D-3L as a target measure, was also adopted in six submissions, although it was somewhat unfavourably described in the guideline. Notably, 52.2% of the submissions with published sources took utility values from different sources for different health states defined in a single model. In addition, details of utility measurement methods or mapping functions taken from published sources were relatively poorly reported. Moreover, the preferences of the Korean general public, preferred by the guideline, were rarely reflected in the utility values used in submissions relying on published sources (95.7% for foreign values only/mixed) and mapping (66.7%). While most submissions with direct and indirect methods used domestic preference values, the former was occasionally criticised by assessment committees because of health state descriptions. This review highlights a considerable amount of inconsistency in the measurement of utility values used in the PE submissions during 2014–2018, indicating a strong need for methodological standardisation.
- Open Access
- 27 May 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (10) , 1869
Decomposing Income-Related Inequalities in Self-Reported Depression and Self-Rated Health Among Married Immigrants in South Korea
Health inequalities among immigrant minorities have been under-researched in South Korea. This study, therefore, measured the extent of income-related inequalities in self-reported depression and self-rated health (SRH) among married immigrants in South Korea and decomposed them into sociodemographic determinants using data from the 2015 National Survey of Multicultural Families (n = 15,231). The mean age of this sample was 37.8 years (SD = 10.8) and the mean duration of residence was 10.1 years (SD = 7.4). Eighty-five percent were female, and of these, 86.5% were from low/middle-income countries. Of these married immigrants, 34.6% reported experiences of depressive symptoms in the past year, and 9.5% reported their current health to be poor or very poor (weighted). The results also indicated substantial pro-rich health inequalities with the Erreygers concentration index of −0.1298 for self-reported depression and that of −0.1231 for poor SRH. Socioeconomic positions, reflected in income, subjective social status, and employment status, alongside satisfaction with a spouse, appeared to have much greater contributions to the overall inequality than demographics and type of migration. These findings suggest that social welfare policies and programmes can play important roles in reducing health inequalities that are ‘avoidable and unnecessary’ among married immigrants in South Korea.
- 27 May 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (10) , 1869
Open AccessDecomposing Income-Related Inequalities in Self-Reported Depression and Self-Rated Health Among Married Immigrants in South Korea
Health inequalities among immigrant minorities have been under-researched in South Korea. This study, therefore, measured the extent of income-related inequalities in self-reported depression and self-rated health (SRH) among married immigrants in South Korea and decomposed them into sociodemographic determinants using data from the 2015 National Survey of Multicultural Families (n = 15,231). The mean age of this sample was 37.8 years (SD = 10.8) and the mean duration of residence was 10.1 years (SD = 7.4). Eighty-five percent were female, and of these, 86.5% were from low/middle-income countries. Of these married immigrants, 34.6% reported experiences of depressive symptoms in the past year, and 9.5% reported their current health to be poor or very poor (weighted). The results also indicated substantial pro-rich health inequalities with the Erreygers concentration index of −0.1298 for self-reported depression and that of −0.1231 for poor SRH. Socioeconomic positions, reflected in income, subjective social status, and employment status, alongside satisfaction with a spouse, appeared to have much greater contributions to the overall inequality than demographics and type of migration. These findings suggest that social welfare policies and programmes can play important roles in reducing health inequalities that are ‘avoidable and unnecessary’ among married immigrants in South Korea.
- 20 October 2018
- Published by Taylor & Francis in Psychology, Health & Medicine
- Vol. 24 (3) , 305-319
The areas of life dissatisfaction and their relationships to depression at different life stages: findings from a nationally representative survey
This study examined the areas of life dissatisfaction and their relationships to depression at different life stages in men and women, independently of socio-demographic characteristics in South Korea. Data were taken from the 2016 Korea Welfare Panel Study. Depression was assessed using the 11-items of the Center for Epidemiologic Studies Depression Scale (CES-D) and probable depression was defined as the CES-D-11 score of ≥9. Level of satisfaction was measured in seven different life domains (health, family income, residential environment, family relationship, occupation, social relationship and leisure activities) using a 5-point Likert scale. Dissatisfaction was defined as ‘very dissatisfied’ and ‘dissatisfied’. Respondents were grouped into: young (19–39 years; n = 2,713), middle-aged (40–64; n = 4,864) and older adults (65+; n = 4,669). The mean age of the participants was 56.0 years (SD = 18.6) and 57.1% were female (unweighted). The mean CES-D-11 score was 3.5 (SD = 4.8) and 13.7% (n = 1,675) had probable depression (unweighted). The percentage of domain-specific dissatisfaction was highest in family income (28.7%), followed by health (15.9%), leisure activities (14.9%), occupation (11.6%), residential environment (10.2%), social relationship (3.5%) and family relationship (3.0%) (weighted). These percentages were similar across all age groups, except for health and family income in both sexes. In addition, the association between domain-specific dissatisfaction and probable depression was generally stronger in women than in men across all age groups. Logistic regression results (weighted) showed that dissatisfaction with health and leisure activities were consistently associated with probable depression across almost all age groups in both sexes. In addition, family relationship appeared more important in older women, whereas social relationship appeared more important in older men. Meanwhile, dissatisfaction with family income and occupation did not appear to consistently predict depression above and beyond objective indicators, except for older women. Taken together, these findings would help develop sex- and age-specific policies to tackle depression in South Korea.
- 20 October 2018
- Published by Taylor & Francis in Psychology, Health & Medicine
- Vol. 24 (3) , 305-319
The areas of life dissatisfaction and their relationships to depression at different life stages: findings from a nationally representative survey
This study examined the areas of life dissatisfaction and their relationships to depression at different life stages in men and women, independently of socio-demographic characteristics in South Korea. Data were taken from the 2016 Korea Welfare Panel Study. Depression was assessed using the 11-items of the Center for Epidemiologic Studies Depression Scale (CES-D) and probable depression was defined as the CES-D-11 score of ≥9. Level of satisfaction was measured in seven different life domains (health, family income, residential environment, family relationship, occupation, social relationship and leisure activities) using a 5-point Likert scale. Dissatisfaction was defined as ‘very dissatisfied’ and ‘dissatisfied’. Respondents were grouped into: young (19–39 years; n = 2,713), middle-aged (40–64; n = 4,864) and older adults (65+; n = 4,669). The mean age of the participants was 56.0 years (SD = 18.6) and 57.1% were female (unweighted). The mean CES-D-11 score was 3.5 (SD = 4.8) and 13.7% (n = 1,675) had probable depression (unweighted). The percentage of domain-specific dissatisfaction was highest in family income (28.7%), followed by health (15.9%), leisure activities (14.9%), occupation (11.6%), residential environment (10.2%), social relationship (3.5%) and family relationship (3.0%) (weighted). These percentages were similar across all age groups, except for health and family income in both sexes. In addition, the association between domain-specific dissatisfaction and probable depression was generally stronger in women than in men across all age groups. Logistic regression results (weighted) showed that dissatisfaction with health and leisure activities were consistently associated with probable depression across almost all age groups in both sexes. In addition, family relationship appeared more important in older women, whereas social relationship appeared more important in older men. Meanwhile, dissatisfaction with family income and occupation did not appear to consistently predict depression above and beyond objective indicators, except for older women. Taken together, these findings would help develop sex- and age-specific policies to tackle depression in South Korea.
- Open Access
- 3 August 2018
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 16 (1) , 159
Relative importance of the EQ-5D five dimensions among patients with chronic diseases in South Korea – a comparison with the general population preference weights
Who should provide the values of health states in economic evaluations of health technologies has long been the subject of debate. This study examined and compared the relative importance of the EQ-5D five dimensions, using both patient-reported values and general population tariffs, among patients with chronic diseases in South Korea and also assessed the pattern of the discrepancy between patient and general population values by type of chronic diseases. Data were taken from the 2013 Korea Health Panel survey. This analysis focused on adult patients with chronic diseases (n = 3216). Patient-reported EQ-5D profiles and visual analogue scale (VAS) values were used to assess the relative importance of the EQ-5D five dimensions among these patients, using a linear regression model. The relative importance of the EQ-5D dimensions was then compared to the EQ-5D tariffs elicited from the general population. The relative magnitude of the discrepancies between patient and general population values was also assessed by type of chronic diseases. Anxiety/depression and pain/discomfort appeared to have the largest impact on the self-rated patient VAS, which fairly contrasted with the general population model. In addition, a further regression analysis showed that the discrepancy between patient and general population values varied with the type of chronic diseases. The greatest discrepancy between the two was found in patients with diseases of the blood and blood-forming organs, neoplasms and diseases of the digestive system. These analyses revealed differences in the relative weights attached to the EQ-5D dimensions between patient groups and the general population, particularly in those ‘non-tangible’ dimensions. These differences consequently led to greater discrepancies between patient and general population values in certain patient groups, which can have significant implications for resource allocation decisions in South Korea.
- 3 August 2018
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 16 (1) , 159
Open AccessRelative importance of the EQ-5D five dimensions among patients with chronic diseases in South Korea – a comparison with the general population preference weights
Who should provide the values of health states in economic evaluations of health technologies has long been the subject of debate. This study examined and compared the relative importance of the EQ-5D five dimensions, using both patient-reported values and general population tariffs, among patients with chronic diseases in South Korea and also assessed the pattern of the discrepancy between patient and general population values by type of chronic diseases. Data were taken from the 2013 Korea Health Panel survey. This analysis focused on adult patients with chronic diseases (n = 3216). Patient-reported EQ-5D profiles and visual analogue scale (VAS) values were used to assess the relative importance of the EQ-5D five dimensions among these patients, using a linear regression model. The relative importance of the EQ-5D dimensions was then compared to the EQ-5D tariffs elicited from the general population. The relative magnitude of the discrepancies between patient and general population values was also assessed by type of chronic diseases. Anxiety/depression and pain/discomfort appeared to have the largest impact on the self-rated patient VAS, which fairly contrasted with the general population model. In addition, a further regression analysis showed that the discrepancy between patient and general population values varied with the type of chronic diseases. The greatest discrepancy between the two was found in patients with diseases of the blood and blood-forming organs, neoplasms and diseases of the digestive system. These analyses revealed differences in the relative weights attached to the EQ-5D dimensions between patient groups and the general population, particularly in those ‘non-tangible’ dimensions. These differences consequently led to greater discrepancies between patient and general population values in certain patient groups, which can have significant implications for resource allocation decisions in South Korea.
- 28 June 2018
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 21 (3) , 522-532
Effects of Ethnic Identity on the Relationship Between Mental Health and Perceived Discrimination Among Ethnic Return Migrants: The Case of Korean Chinese Return-Migrated to South Korea
This study examined the relationship among mental health, perceived discrimination and ethnic identity among Korean Chinese (Joseonjok) who have return-migrated to South Korea. A survey was conducted with 399 Joseonjok adults (≥ 19 years) residing in the capital city Seoul or nearby. Depression was measured using the (self-report) Center for Epidemiologic Studies Depression Scale-Korean (CES-D-K) version (n = 292, mean age = 42.6, female = 56.5%). Perceived discrimination and ethnic identity were assessed with single-item questions. The mean CES-D-K total score was 9.3 (SD = 8.4) and 20.6% had clinical depression (cut-off score: 16). Perceived discrimination was positively associated with CES-D-K scores (regression coefficient = 2.09, p = 0.04). This association was stronger in those identifying themselves more strongly as ‘Korean’ than ‘Chinese’. Discrimination by ‘co-ethnic hosts’ can have a greater impact on mental health among those ethnic return migrants with a stronger ethnic identity. More efforts are needed to help them better integrate into South Korean society.
- 28 June 2018
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 21 (3) , 522-532
Effects of Ethnic Identity on the Relationship Between Mental Health and Perceived Discrimination Among Ethnic Return Migrants: The Case of Korean Chinese Return-Migrated to South Korea
This study examined the relationship among mental health, perceived discrimination and ethnic identity among Korean Chinese (Joseonjok) who have return-migrated to South Korea. A survey was conducted with 399 Joseonjok adults (≥ 19 years) residing in the capital city Seoul or nearby. Depression was measured using the (self-report) Center for Epidemiologic Studies Depression Scale-Korean (CES-D-K) version (n = 292, mean age = 42.6, female = 56.5%). Perceived discrimination and ethnic identity were assessed with single-item questions. The mean CES-D-K total score was 9.3 (SD = 8.4) and 20.6% had clinical depression (cut-off score: 16). Perceived discrimination was positively associated with CES-D-K scores (regression coefficient = 2.09, p = 0.04). This association was stronger in those identifying themselves more strongly as ‘Korean’ than ‘Chinese’. Discrimination by ‘co-ethnic hosts’ can have a greater impact on mental health among those ethnic return migrants with a stronger ethnic identity. More efforts are needed to help them better integrate into South Korean society.
- Open Access
- 30 September 2017
- Published by Bentham Science Publishers Ltd. in Clinical Practice & Epidemiology in Mental Health
- Vol. 13 (1) , 145-155
Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East
Background: The Global Burden of Disease 2010 study reported the relative size of major depressive disorder (MDD) burden to be greater in the Middle East and North Africa than anywhere else. However, little research has been carried out to examine the comparative effectiveness of antidepressants in this region.Objective: To assess and compare functioning levels in Middle Eastern patients with MDD treated with either duloxetine or a selective serotonin reuptake inhibitor (SSRI), and to examine the impacts of depression-related pain on functioning by the type of treatment.Method: This post-hoc analysis, which focused on Middle Eastern patients, used data from a 6-month prospective observational study that included 1,549 MDD patients without sexual dysfunction. Levels of functional impairment and depression-related pain were assessed using the Sheehan Disability Scale (SDS) and the modified Somatic Symptom Inventory, respectively. A mixed model with repeated measures (MMRM) was employed.Results: The mean age of the patients was 37.3 (SD=8.4) years, and 34.6% were female. Patient functioning was, on average, moderately impaired at baseline, but improved substantially during follow-up in both the duloxetine (n=152) and the SSRI (n=123) cohorts. The MMRM results showed a lower level of functional impairment at 24 weeks in the duloxetine cohort than in the SSRI cohort (p<0.001). Pain severity at baseline was positively associated with functional impairment during follow-up only in the SSRI cohort (p=0.003).Conclusion: Duloxetine-treated MDD patients achieved better functioning than SSRI-treated patients. This treatment difference was partly driven by depression-related pain.
- 30 September 2017
- Published by Bentham Science Publishers Ltd. in Clinical Practice & Epidemiology in Mental Health
- Vol. 13 (1) , 145-155
Open AccessFunctional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East
Background: The Global Burden of Disease 2010 study reported the relative size of major depressive disorder (MDD) burden to be greater in the Middle East and North Africa than anywhere else. However, little research has been carried out to examine the comparative effectiveness of antidepressants in this region.Objective: To assess and compare functioning levels in Middle Eastern patients with MDD treated with either duloxetine or a selective serotonin reuptake inhibitor (SSRI), and to examine the impacts of depression-related pain on functioning by the type of treatment.Method: This post-hoc analysis, which focused on Middle Eastern patients, used data from a 6-month prospective observational study that included 1,549 MDD patients without sexual dysfunction. Levels of functional impairment and depression-related pain were assessed using the Sheehan Disability Scale (SDS) and the modified Somatic Symptom Inventory, respectively. A mixed model with repeated measures (MMRM) was employed.Results: The mean age of the patients was 37.3 (SD=8.4) years, and 34.6% were female. Patient functioning was, on average, moderately impaired at baseline, but improved substantially during follow-up in both the duloxetine (n=152) and the SSRI (n=123) cohorts. The MMRM results showed a lower level of functional impairment at 24 weeks in the duloxetine cohort than in the SSRI cohort (p<0.001). Pain severity at baseline was positively associated with functional impairment during follow-up only in the SSRI cohort (p=0.003).Conclusion: Duloxetine-treated MDD patients achieved better functioning than SSRI-treated patients. This treatment difference was partly driven by depression-related pain.
- Open Access
- 16 September 2017
- Published by Springer Nature in BMC Health Services Research
- Vol. 17 (1) , 663
The economic burden of advanced gastric cancer in Taiwan
Gastric cancer is one of the leading causes of cancer-related deaths in both sexes worldwide, especially in Eastern Asia. This study aimed to estimate the economic burden of advanced gastric cancer (AGC) in Taiwan. The costs of AGC in 2013 were estimated using resource use data from a chart review study (n = 122 with AGC) and national statistics. Annual per-patient costs, where patients’ follow-up periods were adjusted for, were estimated with 82 patients who had complete resource use data. The costs were composed of direct medical costs, direct non-medical costs (healthcare travel and caregiver costs), morbidity costs, and mortality costs. Relevant unit costs were retrieved mainly from literature and national statistics, and applied to the resource use data. A broad definition of morbidity and mortality costs was employed to value the productivity loss in patients with unpaid employment, economically inactive and unemployed as well as the life years after the age of retirement. Their narrow definitions were also used in sensitivity analyses, using age- and/or sex-specific employment rates. Forgone future earnings/productivity loss were discounted at 3%. Annual per-patient costs were projected to estimate the total costs of AGC at the national level with an estimated number of patients with AGC (N = 2611) in Taiwan in 2013. The mean age of the 82 patients was 59.3 (SD: 11.9) years, and 67.1% were male. Per-patient costs were US$26,431 for direct medical costs, US$4669 for direct non-medical costs, US$5758 for morbidity costs, and US$145,990 for mortality costs (per death). These per-patient costs were projected to incur total AGC costs of US$423 million at the national-level. Mortality costs accounted for 77.3% of the total costs, followed by direct medical costs (16.3%), morbidity costs (3.6%), and direct non-medical costs (2.9%). AGC was found to exert a significant economic burden in Taiwan, incurring US$423 million in 2013. This represents about 0.08% of the Taiwanese economy. Mortality costs appeared to be the single greatest contributor to the burden, followed by direct medical costs. Early detection and providing effective treatments will help to reduce its burden on patients, caregivers and society as a whole. A poster of this study was presented at the 2016 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco, CA, USA.
- 16 September 2017
- Published by Springer Nature in BMC Health Services Research
- Vol. 17 (1) , 663
Open AccessThe economic burden of advanced gastric cancer in Taiwan
Gastric cancer is one of the leading causes of cancer-related deaths in both sexes worldwide, especially in Eastern Asia. This study aimed to estimate the economic burden of advanced gastric cancer (AGC) in Taiwan. The costs of AGC in 2013 were estimated using resource use data from a chart review study (n = 122 with AGC) and national statistics. Annual per-patient costs, where patients’ follow-up periods were adjusted for, were estimated with 82 patients who had complete resource use data. The costs were composed of direct medical costs, direct non-medical costs (healthcare travel and caregiver costs), morbidity costs, and mortality costs. Relevant unit costs were retrieved mainly from literature and national statistics, and applied to the resource use data. A broad definition of morbidity and mortality costs was employed to value the productivity loss in patients with unpaid employment, economically inactive and unemployed as well as the life years after the age of retirement. Their narrow definitions were also used in sensitivity analyses, using age- and/or sex-specific employment rates. Forgone future earnings/productivity loss were discounted at 3%. Annual per-patient costs were projected to estimate the total costs of AGC at the national level with an estimated number of patients with AGC (N = 2611) in Taiwan in 2013. The mean age of the 82 patients was 59.3 (SD: 11.9) years, and 67.1% were male. Per-patient costs were US$26,431 for direct medical costs, US$4669 for direct non-medical costs, US$5758 for morbidity costs, and US$145,990 for mortality costs (per death). These per-patient costs were projected to incur total AGC costs of US$423 million at the national-level. Mortality costs accounted for 77.3% of the total costs, followed by direct medical costs (16.3%), morbidity costs (3.6%), and direct non-medical costs (2.9%). AGC was found to exert a significant economic burden in Taiwan, incurring US$423 million in 2013. This represents about 0.08% of the Taiwanese economy. Mortality costs appeared to be the single greatest contributor to the burden, followed by direct medical costs. Early detection and providing effective treatments will help to reduce its burden on patients, caregivers and society as a whole. A poster of this study was presented at the 2016 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco, CA, USA.